INFICURE BIO
InfiCure Bio is a life science company, which started as a project at Umeå Biotech Incubator (UBI) in 2013. The project was initiated by Prof. Dan Holmberg and Dr. Sofia Mayans based on research conducted in the research group of Prof. Holmberg at the Universities of Umeå and Lund. The company, InfiCure Bio, was established in 2015 and the founders of the company are Dan Holmberg and Sofia Mayans. he base of the company is a unique preclinical model for studies of fibrosis together with the o... wners’ competence in the field of inflammation/fibrosis as well as in work with preclinical models. Development of fibrosis in the model is spontaneous, seen in multiple organs (e.g. liver and kidney) and is preceded by chronic inflammation. This resembles many of the human condition that constitute important therapy segments eg chronic liver disease and chronic kidney disease. The company’s preferred business model is to offer pharmaceutical companies to test their new anti-inflammatory/anti-fibrotic drugs in the unique preclinical model. The offer includes set-up, execution, analysis and reporting of results from the effect tests.
INFICURE BIO
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Umeå, Vasterbottens Lan, Sweden
Country:
Sweden
Website Url:
http://www.inficurebio.com
Total Employee:
1+
Status:
Active
Contact:
+46(0)70-366 4666
Email Addresses:
[email protected]
Total Funding:
59.47 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt WordPress Apache Wordpress Plugins Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - InfiCure Bio
Partnerinvest Norr
Partnerinvest Norr investment in Seed Round - InfiCure Bio
More informations about "InfiCure Bio"
InfiCure Bio - Crunchbase Company Profile & Funding
Organization. InfiCure Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contact Email [email protected]; …See details»
InfiCure Bio Company Profile 2025: Valuation, Funding ... - PitchBook
InfiCure Bio General Information Description. Operator of a life science company intended to focus on preclinical development and validation of drugs. The company offers drugs that …See details»
InfiCure Bio AB | Scientist.com
Inficurebio.com: Headquarters: Västerbottens län, SE Company Type: New Startup (0-1M TTM Revenue) Description Sites Preclinical CRO in the field of inflammation and fibrosis. We have …See details»
Strong start to 2023 for InfiCure Bio - UBI
Feb 7, 2023 InfiCure Bio is a contract research organization located in Umeå, Sweden focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions. The company was founded in …See details»
Inficure Bio AB - Company Profile and News - Bloomberg Markets
Company profile page for Inficure Bio AB including stock price, company news, executives, board members, and contact informationSee details»
InfiCure Bio signs agreement with two major …
Oct 12, 2022 [email protected]. About Inficure Bio Inficure Bio is a life science company with a focus on preclinical development of new drugs for the treatment of chronic inflammatory and fibrotic conditions. The company has a …See details»
InfiCure Bio - Products, Competitors, Financials, Employees ...
Sofia Mayans joins Diamyd Medical. Oct 14, 2024. Sofia Mayans joins Diamyd Medical Sofia Mayans Photo: Fredrik Larsson Sofia Mayans, who transitioned from her research to co …See details»
InfiCure Bio Company Profile - Craft
InfiCure Bio has 5 employees at their 1 location and $59.36 k in total funding,. See insights on InfiCure Bio including office locations, competitors, revenue, financials, executives, …See details»
Startup Showcase: InfiCure Bio – Trailblazing Research
Aug 2, 2023 In the dynamic world of biotechnology, the freshest innovator to step into the spotlight is InfiCure Bio. Headquartered in the thriving life sciences hub of Umeå, Sweden, …See details»
InfiCure Bio AB - CMOCRO
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions. Based on a panel of in vivo models for …See details»
InfiCure Bio Aktiebolag - VentureRadar
C.RIS Pharma France n/a C.RIS Pharma is a Contract Research Organization (CRO) specialized in non-clinical safety studies for product registration according to current international …See details»
Inficure Bio attract millions in new funding round - UBI
Aug 6, 2019 Life science company Inficure Bio attract millions in new funding round. “Attracting new investment allows us to move faster. We have lots of potential customers and we want to …See details»
InfiCure Bio CEO and Key Executive Team | Craft.co
InfiCure Bio's Board Member is Mattias Eriksson. Other executives include Mattias Pettersson, Board Member; Sofia Mayans, CEO and Board member. See the full leadership team at Craft.See details»
Startup Showcase: InfiCure Bio – Trailblazing Research
Aug 2, 2023 Revolutionizing Fibrosis Research. The uniqueness of InfiCure Bio lies in its proprietary preclinical model for studying fibrosis. Developed from extensive research …See details»
Pioneering fibrosis startup secures backing to reach global market
Oct 3, 2017 Inficure Bio has signed an investment deal acquiring external venture capital for the first time. The new partners contribute with broad competence and funding - and within one …See details»
InfiCure Bio
[email protected] +46 70 366 46 66 Website www.inficurebio.com Therapeutic area Pre-clinical drug validation Development stage International sales ongoing. Licence option …See details»
InfiCure Bio secures US patent and publishes new data in a top ...
Dec 18, 2020 [email protected]. About Inficure Bio. Inficure Bio is a life science company that focuses on preclinical development of new drugs for the treatment of chronic …See details»
InfiCure Bio Aktiebolag - VentureRadar
TRIGA-S e.K. Scientific Solutions Unknown n/a TRIGA-S is a Contract Research Organization (CRO) with its own S2 laboratory, specializing in In-vitro diagnostics and medical devices. …See details»
InnoSer and Inficure Bio enter partnership to increase accessibility …
Oct 27, 2022 Inficure Bio and InnoSer have teamed up to offer Inficure Bio’s spontaneous liver inflammation & fibrosis mouse model (NIF mouse) as part of InnoSer’s expanding cardio …See details»
Breakthrough for Inficure Bio about liver and kidney fibrosis
Dec 8, 2021 [email protected]. About Inficure Bio Inficure Bio is a life science company focused on preclinical development of drugs for treatment of chronic inflammatory …See details»